Related Experiment Video
Updated: May 4, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion
Han Li1, Yashu Liu2, Pinghua Gong1
1State Key Laboratory on Intelligent Technology and Systems, Tsinghua National Laboratory for Information Science and Technology (TNList), Department of Automation, Tsinghua University, Beijing, P.R. China.
Abstract:
Identifying patients with Mild Cognitive Impairment (MCI) who are likely to convert to dementia has recently attracted increasing attention in Alzheimer's disease (AD) research. An accurate prediction of conversion from MCI to AD can aid clinicians to initiate treatments at early stage and monitor their effectiveness. However, existing prediction systems based on the original biosignatures are not satisfactory. In this paper, we propose to fit the prediction models using pairwise biosignature interactions, thus capturing higher-order relationship among biosignatures. Specifically, we employ hierarchical constraints and sparsity regularization to prune the high-dimensional input features. Based on the significant biosignatures and underlying interactions identified, we build classifiers to predict the conversion probability based on the selected features. We further analyze the underlying interaction effects of different biosignatures based on the so-called stable expectation scores. We have used 293 MCI subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) database that have MRI measurements at the baseline to evaluate the effectiveness of the proposed method. Our proposed method achieves better classification performance than state-of-the-art methods. Moreover, we discover several significant interactions predictive of MCI-to-AD conversion. These results shed light on improving the prediction performance using interaction features.
Insights
Predicting dementia conversion in Mild Cognitive Impairment (MCI) is crucial for early Alzheimer's disease (AD) treatment. This study introduces a novel method using biosignature interactions, significantly improving prediction accuracy over existing approaches.
Area of Science:
- Neuroscience
- Medical Imaging
- Biostatistics
Background:
- Accurate prediction of Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) conversion is vital for early intervention.
- Current prediction systems using individual biosignatures are insufficient for reliable forecasting.
Purpose of the Study:
- To develop an improved prediction model for MCI to AD conversion by incorporating pairwise biosignature interactions.
- To identify significant biosignatures and their interactions that predict conversion to dementia.
Main Methods:
- Utilized hierarchical constraints and sparsity regularization for feature selection from high-dimensional biosignature data.
- Developed classification models based on significant biosignatures and their interactions.
- Analyzed biosignature interaction effects using stable expectation scores.
Main Results:
- The proposed method demonstrated superior classification performance compared to state-of-the-art techniques.
- Identified several significant pairwise biosignature interactions that are predictive of MCI to AD conversion.
- The study utilized MRI data from 293 MCI subjects in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
Conclusions:
- Incorporating biosignature interactions enhances the accuracy of MCI to AD conversion prediction.
- The findings offer new insights into the complex interplay of biosignatures in AD progression.
- This approach holds promise for improving early diagnosis and monitoring of Alzheimer's disease.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease l: Introduction
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Treatment